DÄ internationalArchive46/2007Aspirin Sensitive Asthma

Review article

Aspirin Sensitive Asthma

Dtsch Arztebl 2007; 104(46): A-3178

Randerath, W J; Galetke, W

For technical reasons, the English full text will be published approximately two weeks after the German print edition has been published.

1. Schapowal AG, Simon HU, M. Schmitz-Schumann: Phenomenology, pathogenesis, diagnosis and treatment of aspirin-sensitive rhinosinusitis. Acta oro-rhino-laryngologica belg 1995; 49: 235–50. MEDLINE
2. Marquette CH, Saulnier F, Leroy O et al.: Long-term prognosis for near-fatal asthma. A 6-year follow-up study of 145 asthmatic patients who underwent mechanical ventilation for near-fatal attack of asthma. Am Rev Respir Dis 1992; 146: 76–81. MEDLINE
3. Karl S, Brederlow C, Bruckbauer HR, Vocks E: Intoleranzreaktionen auf Acetylsalizylsäure bei bestehender Grunderkrankung. Allergologie 1994; 17: 239–41.
4. Stevenson DD: Diagnosis prevention and treatment of adverse reactions to aspirin and nonsteroidal antiinflammatory drugs. J Allergy Clin Immunol 1984; 74: 617–22. MEDLINE
5. Szczeklik A, Gryglewski RJ, Czerniawska-Mysik G: Relationship of inhibition of prostaglandin biosynthesis by analgesia to asthma attacks in aspirin-sensitive patients. Br Med J 1975; 1: 67–9. MEDLINE
6. Randerath W: Das Analgetika-Asthma-Syndrom. In: Randerath W (Hrsg.): Bronchialtherapeutika. Medizinisch-Pharmakologisches Kompendium Band 17. Stuttgart: Wissenschaftliche Verlagsgesellschaft 2007; 123–33.
7. Estrada-Rodriguez JL, Florido-Lopez JF, Belchi-Hernandez J et al.: Asthma in children and ASA intolerance. J Investig Allergol Clin Immunol 1993; 3: 315–20. MEDLINE
8. Jenkins C, Costello J, Hodge L: Systematic review of prevalence of aspirin induced asthma and its implications for clinical practice. BMJ 2004; 328: 434. MEDLINE
9. Lewis RA, Austen KF, Sobermann RJ: Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases. N Engl J Med 1990; 323: 645–55. MEDLINE
10. Kim SH, Park HS: Genetic markers for differentiating aspirin-hypersensitivity. Yonsei Med J 2006; 47: 15–21. MEDLINE
11. Arm JP, Lee TH: Evidence for a specific role of leukotriene E4 in asthma and airway hyperresponsiveness. In: Dahlén SE (ed): Advances in prostaglandin, thromboxane and leukotriene research. New York: Raven Press Ltd. 1994; 227–40.
12. Cowburn AS, Sladek K, Soja J et al.: Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma. J Clin Invest 1998; 101: 834. MEDLINE
13. Antczak A, Montuschi P, Kharitonov S et al.: Increased exhaled cysteinyl-leukotrienes and 8-isoprostane in aspirin-induced asthma. Am J Respir Crit Care Med 2002; 166: 301. MEDLINE
14. Kowalski ML, Pawliczak R, Wozniak J et al.: Differential metabolism of arachidonic acid in nasal polyp epithelial cells cultured from ASA-sensitive and ASA-tolerant patients. Am J Respir Crit Care Med 2000; 161: 391–8. MEDLINE
15. Picado C, Fernandez-Morata JC, Juan M et al.: Cyclooxygenase-2 mRNA is downexpressed in nasal polyps from aspirin-sensitive asthmatics. Am J Respir Crit Care Med 1999; 160: 291–6. MEDLINE
16. Szczeklik A: Aspirin-induced asthma: an update and novel findings. In: Dahlén, SE et al. (Hrsg.): Advances in Prostaglandin, Thromboxane and Leukotriene Research. New York: Raven Press Ltd. 1994; 227–40.
17. Sladek K, Dworski R, Soja J et al.: Eicosanoids in bronchoalveolar lavage fluid of aspirin-intolerant patients with asthma after aspirin challenge. Am J Respir Crit Care Med 1994; 149: 940–6. MEDLINE
18. Patriarca G, Nucera E, DiRienzo V et al.: Nasal provocation test with lysine acetylsalicylate in aspirin-sensitive patients. Allergy 1991; 67: 60–2. MEDLINE
19. Park HS: Early and late onset asthmatic responses following lysine-aspirin inhalation in aspirin-sensitive asthmatic patients. Clinical and Experimental Allergy 1995; 25: 38–40. MEDLINE
20. Nizankowska E, Bestynska-Krypel A, Cmiel A et al.: Oral and bronchial provocation tests with aspirin for diagnosis of aspirin-induced asthma. Eur Respir J 2000; 15: 863–9. MEDLINE
21. Kowalski ML, Makowska J: Use of nonsteroidal antiinflammatory drugs in patients with aspirin hypersensitivity: safety of cyclo-oxygenase-2 inhibitors. Treat Respir Med 2006; 5: 399–406. MEDLINE
22. Pleskow WW, Stevenson DD, Mathison DA et al.: Aspirin desensitization in aspirin-sensitive asthmatic patients: clinical manifestations and characterization of the refractory period. J Allergy Clin Immunol 1982; 69: 11–9. MEDLINE
23. Lee JY, Simon RA, Stevenson DD: Selection of aspirin dosages for aspirin desensitization treatment in patients with aspirinexacerbated respiratory disease. J Allergy Clin Immunol 2007; 119: 157–64. MEDLINE
24. Dahlen SE, Malmstrom K, Nizankowska E et al.: Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial. Am J Respir Crit Care Med 2002; 165: 9–14. MEDLINE
25. Mastalerz L, Milewski M, Duplaga M et al.: Intranasal fluticasone propionate for chronic eosinophilic rhinitis in patients with aspirin-induced asthma. Allergy 1997; 52: 895–900. MEDLINE
e1. Widal MF, Abramin P, Lermoyez J: Anaphylaxie et idiosyncrasie. Presse Med 1922; 30: 189.
e2. Stevenson DD, Simon RA, Lumry WR, Mathison DA: Adverse reactions to tartrazine. J Allergy Clin Immunol 1986; 78:182–91. MEDLINE
e3. Szczeklik A, Nizankowska E, Czerniawska-Mysik Get al.: Hydrocortisone and airflow impairment in aspirin-induced asthma. J Allergy Clin Immunol 1985; 76: 530–6. MEDLINE
e4. Szczeklik A, Dworski R, Mastalerz L et al: Salmeterol prevents aspirin-precipitated attacks of asthma and interferes with eicosanoid metabolism. Am J Respir Crit Care Med 1998; 158: 1168–72. MEDLINE

Info

Specialities